UVB rays
Coverage of UVB rays in the Nexus archive.
- DC dermatologist calls new FDA-approved sunscreen ingredient a ‘meaningful step forward’
The FDA has approved bemotrizinol, a sunscreen ingredient previously used in Europe, offering enhanced protection against UVB and UVA rays. Dr. Adam Friedman, a dermatologist at George Washington University, highlights its photostability, potential to improve existing sunscreens, and public health benefits in preventing skin aging and cancer.
- FDA approves new sunscreen ingredient
The FDA approved Bemotrizinol, a sunscreen ingredient previously used in Europe and Asia, for use in the U.S. The chemical compound provides protection against UVA and UVB rays.
- The FDA is approving its first new sunscreen ingredient in more than 20 years
The FDA is approving Bemotrizinol, its first new sunscreen ingredient in over 20 years, which blocks both UVA and UVB rays and is cleared for use by adults and children 6 months and older. The ingredient has been available in Europe and is now being recognized for broader use in the U.S.
- The FDA just glowed up your sunscreen — by approving a popular ingredient in European and Asian formulas
The FDA approved bemotrizinol, a UVA/UVB-blocking sunscreen ingredient popular in Europe and Asia, marking the first new sunscreen ingredient approved in the U.S. since 1999. This update addresses U.S. sunscreen's historical lag in effectiveness and smooth application, though new products will take over a year to reach consumers.